2023 GOLD International COPD Conference
octubre 30, 2023
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
Register now for the Caribbean Regional COPD Symposium – Commemorating World COPD Day 2023 «Breathing is Life – Shifting Perspectives on COPD». Next Sunday, October 29, 2023, from 11:30 a.m. (ECT) / 10:30 a.m. (JA).
Entrevista al Dr. Alvar Agustí en Castilla-La Mancha Despierta para hablar de la importancia diagnóstico temprano de la EPOC.
NOVEDADES GOLD 2024, Reunión mixta el próximo 21 Noviembre 2023, de 17 a 19h. Regístrate cuanto antes (gratuito) en la modalidad Online o Presencial.
The results of this post hoc analysis support the hypothesis that benralizumab reduces the risk for recurrent COPD exacerbations within the vulnerable 30-to-90–day period in the previously identified responder population.
Mediante esta noticia ponemos a vuestra disposición los documentos de las presentaciones de Alvar Agustí durante la sesión del Webinar «JOINT WEBINAR ON COPD 2023 GUIDELINES»
Joint webinar on GOLD COPD GUIDELINES, Next Saturday, 12 August 2023 from 8:00 to 9:10 (CEST/UTC+2)
GOLD Scientific Committee responses the five letters received in relation to the recent publication of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023.
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
The use of biologic therapies, including monoclonal antibodies, has revolutionized the treatment of many human diseases.